Showing results (81-90 of 368) with videos related to

Sort By:
Pageof 37
Bone Reports|October 27, 2018
Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutationKathleen Ang, Elizabeth Sanchez Rangel, Qianying Yuan, et al.
Diabetes Care|November 20, 2012
The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapyPascale Fouqueray, Valdis Pirags, Silvio E Inzucchi, et al.
Circulation. Cardiovascular Quality and Outcomes|November 15, 2021
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United StatesVeer Sangha, Kasia Lipska, Zhenqiu Lin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximabJing Hughes, Garni Barkhoudarian, Pedro Ciarlini, et al.
Diabetologia|May 20, 2018
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trialSubodh Verma, C David Mazer, David Fitchett, et al.
Nature Clinical Practice. Endocrinology & Metabolism|November 21, 2007
A patient with type B insulin resistance syndrome, responsive to immune therapyKathleen A Page, Stephanie Dejardin, C Ronald Kahn, et al.
Diabetes Care|April 12, 2014
The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapyPascale Fouqueray, Valdis Pirags, Michaela Diamant, et al.
Circulation|February 9, 2005
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational studyFrederick A Masoudi, Silvio E Inzucchi, Yongfei Wang, et al.
Endocrine|March 13, 2020
Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance ImagingAmit Mahajan, Richard A Bronen, Ali Y Mian, et al.
Diabetologia|May 2, 2018
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®Bernard Zinman, Silvio E Inzucchi, Christoph Wanner, et al.
Pageof 37